PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.93%
Negative revenue growth while ON stands at 1.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-29.32%
Negative gross profit growth while ON is at 87.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
89.00%
EBIT growth 50-75% of ON's 138.01%. Martin Whitman would suspect suboptimal resource allocation.
89.00%
Operating income growth at 50-75% of ON's 133.71%. Martin Whitman would doubt the firm’s ability to compete efficiently.
103.86%
Net income growth at 75-90% of ON's 135.03%. Bill Ackman would press for improvements to catch or surpass competitor performance.
105.56%
EPS growth at 75-90% of ON's 135.65%. Bill Ackman would push for improved profitability or share repurchases to catch up.
105.56%
Diluted EPS growth at 75-90% of ON's 135.65%. Bill Ackman would expect further improvements in net income or share count reduction.
0.07%
Slight or no buybacks while ON is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.33%
Slight or no buyback while ON is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.01%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-109.49%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-487.33%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
20.18%
10Y revenue/share CAGR under 50% of ON's 71.75%. Michael Burry would suspect a lasting competitive disadvantage.
8.64%
5Y revenue/share CAGR under 50% of ON's 19.72%. Michael Burry would suspect a significant competitive gap or product weakness.
-27.24%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-140.49%
Negative 5Y OCF/share CAGR while ON is at 17.99%. Joel Greenblatt would question the firm’s operational model or cost structure.
-118.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-89.63%
Negative 10Y net income/share CAGR while ON is at 245.86%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-87.29%
Negative 5Y net income/share CAGR while ON is 12132.26%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-95.45%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
176.77%
5Y equity/share CAGR 1.25-1.5x ON's 142.72%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
73.88%
3Y equity/share CAGR 1.25-1.5x ON's 54.30%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
88.03%
Dividend/share CAGR of 88.03% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
40.38%
Dividend/share CAGR of 40.38% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
36.61%
3Y dividend/share CAGR of 36.61% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-2.29%
Firm’s AR is declining while ON shows 12.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.58%
Inventory growth well above ON's 0.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.42%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.99%
BV/share growth above 1.5x ON's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-3.24%
We’re deleveraging while ON stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-55.74%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-10.57%
We cut SG&A while ON invests at 1.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.